Surgical treatment and prognosis analysis of the remnant stomach relapse cancers

doi:10.3877/cma.j.issn.1674-0793.2010.03.011

Abstract

Abstract:

Objective

To investigate the surgical treat efficiency and the prognosis impact of the remnant stomach relapse cancers.

Methods

The clinical data of 30 cases with relapse stomach cancer accepted twice surgical operation were summarized retrospectively from January 1993 to December 2007. The statistical survival analyses were done by Kaplan-Meier and Cox regress model, the validity proof-test were analyzed by Long-rank.

Results

The total average life span were 30.52 months, the middle life span were 25 months. The life span of 19 cases(63.3%) received radical excision were 41.43 months, while 11 cases (36.7%) accepted non-radical excision could survive for 16.85 months medially(P<0.01). The life span were correlated with pathologic staging, diffuse-type, radical matter, peritoneal seeding, liver metastasis (P<0.01), but the factors including sex, age, the time between tumor relapse and the first operation and chemotherapy schedule were no correlated with the survival time.

Conclusions

Clinical staging, peritoneal implantation or radical excision matters are major factors impacting the prognosis of the remnant stomach relapse cancers. The therapeutic effect can still get with the individual healing excision.

Key words: Gastric cancer, Remnant stomach, Relapse, Surgical treat, Prognosis

Jun ZHOU, Zhi-peng JIANG, Bin YANG, Dong-ming LAI, Yu-chao ZHANG, Ying-ru LI, Jie-bo JIN, Shuang CHEN. Surgical treatment and prognosis analysis of the remnant stomach relapse cancers[J]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(03): 228-231.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2010.03.011

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2010/V04/I03/228

项目			例数	Kaplan-Meier			P值
项目			例数	均值	标准误	中位数	P值
病理分期^*			?	?	?	?	?
?	局限期(T2N1M0)		7	54.28	4.10	49	?
?	局部浸润期(T3N2M0)		14	30.43	2.21	28	0.0013
?	晚期(T4N3M1)		9	10.17	0.97	10	?
性别			?	?	?	?	?
?	?	男	23	32.65	3.36	33	0.1743
?	?	女	7	30.23	1.19	31	0.1743
?	年龄(岁)		?	?	?	?	?
?	?	≤ 58	19	32.13	2.94	31	0.9362
?	?	>59	11	30.19	2.87	30	0.9362
?	距首次手术时间(年)		?	?	?	?	?
?	?	≤ 2	18	25.11	2.87	27	0.6475
?	?	>2	12	30.25	1.09	29	0.6475
?	分化程度		?	?	?	?	?
?	?	高、中	12	42.78	2.28	38	0.0018
?	?	低、未^#	18	25.76	1.13	26	0.0018
?	根治情况		?	?	?	?	?
?	?	根治	19	41.43	2.73	39	0.0012
?	?	非根治	11	16.85	1.62	13	0.0012
?	腹膜种植		?	?	?	?	?
?	?	无	27	42.72	2.85	38	0.0013
?	?	有	3	11.03	1.69	12	0.0013
?	肝转移		?	?	?	?	?
?	?	无	27	38.72	2.72	36	0.0012
?	?	有	3	13.35	1.86	15	0.0012
?	盆底种植		?	?	?	?	?
?	?	无	28	42.63	2.74	37	0.0012
?	?	有	2	10.98	1.58	11	0.0012
?	肺转移		?	?	?	?	?
?	?	无	29	43.59	2.54	39	0.0011
?	?	有	1	10.06	1.58	11	0.0011
?	辅助化疗		?	?	?	?	?
?	?	有	24	33.28	3.82	31	0.5367
?	?	无	6	29.78	2.03	28	0.5367

项目			例数	Kaplan-Meier			P值
项目			例数	均值	标准误	中位数	P值
病理分期^*			?	?	?	?	?
?	局限期(T2N1M0)		7	54.28	4.10	49	?
?	局部浸润期(T3N2M0)		14	30.43	2.21	28	0.0013
?	晚期(T4N3M1)		9	10.17	0.97	10	?
性别			?	?	?	?	?
?	?	男	23	32.65	3.36	33	0.1743
?	?	女	7	30.23	1.19	31	0.1743
?	年龄(岁)		?	?	?	?	?
?	?	≤ 58	19	32.13	2.94	31	0.9362
?	?	>59	11	30.19	2.87	30	0.9362
?	距首次手术时间(年)		?	?	?	?	?
?	?	≤ 2	18	25.11	2.87	27	0.6475
?	?	>2	12	30.25	1.09	29	0.6475
?	分化程度		?	?	?	?	?
?	?	高、中	12	42.78	2.28	38	0.0018
?	?	低、未^#	18	25.76	1.13	26	0.0018
?	根治情况		?	?	?	?	?
?	?	根治	19	41.43	2.73	39	0.0012
?	?	非根治	11	16.85	1.62	13	0.0012
?	腹膜种植		?	?	?	?	?
?	?	无	27	42.72	2.85	38	0.0013
?	?	有	3	11.03	1.69	12	0.0013
?	肝转移		?	?	?	?	?
?	?	无	27	38.72	2.72	36	0.0012
?	?	有	3	13.35	1.86	15	0.0012
?	盆底种植		?	?	?	?	?
?	?	无	28	42.63	2.74	37	0.0012
?	?	有	2	10.98	1.58	11	0.0012
?	肺转移		?	?	?	?	?
?	?	无	29	43.59	2.54	39	0.0011
?	?	有	1	10.06	1.58	11	0.0011
?	辅助化疗		?	?	?	?	?
?	?	有	24	33.28	3.82	31	0.5367
?	?	无	6	29.78	2.03	28	0.5367

1	Otsuji E, Kobayashi S, Okamoto K, et al. Is timing of death from tumor recurrence predicable after curative resection for gastric cancer. World J Surg, 2001, 25(11):1373-1376.
2	Roderich ES, Kathryn ZN. Recurrence pattern after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol, 2002, 9(4):394-400.
3	陈峻青.胃癌根治术后复发形式和方法的选择.中国实用外科杂志, 1995, 15(12):709.
4	Kunisaki C, Shimada H, Nomura M, et al. Lymph node dissection in surgical treatment for remnant stomach cancer. Hepato gastroenterology, 2002, 49(44):580-584.
5	Hye SA, Jong WK, Moon-Won Y, et al. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol, 2008, 15(6):1632.

[1]	Xiaoli Yi, Shasha Hu, Yan Zhang. Impact of HER-2 low expression on response of neoadjuvant chemotherapy and prognosis in breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 340-346.
[2]	Yuezhou Li, Kongxi Zhang, Xiaohong Li, Zhonghua Shang. Prognostic significance of PUM in gastric carcinoma based on bioinformatics analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 426-432.
[3]	Jun Zhang, Zai Luo, Mingyu Duan, Zhengjun Qiu, Chen Huang. Research progress of prognostic prediction models for gastric cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 456-461.
[4]	Zaibo Zhang, Bingyu Wang, Zhikai Jiao, Bibo Tan. Risk factors for lower extremity deep venous thrombosis after gastric cancer surgery: A Meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 475-480.
[5]	Qian Yang, Cuifang Li, Wanqiu Zhang. Analysis of short-term and long-term prognosis and influencing factors of primary liver cancer with spontaneous ruptured hemorrhage after emergency TACE surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 33-36.
[6]	Yansong Li, Huimin Feng, Mingchao Liu, Zepeng Liu, Qiuxia Jiang. Expression and clinical significance of STIP1 in triple negative breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 52-56.
[7]	Xu Peng, Yongfu Shao, Duo Li, Rui Zhou, Zhenming Xing. Diagnosis and surgical treatment of hepatocolon flexure [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 108-110.
[8]	Zhenjian Jiang, Ming Jiang, Dali Huang. The expression and prognostic value of TK1 and Ki67 proteins in differentiated thyroid carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 623-626.
[9]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[10]	Xin Lu, Jiayi Xu, Yang Liu, Qin Yang, Wenwen Ju, Yinglong Xu. Comparison of the effects of early LC and PTCD continuous LC on liver function and prognosis of patients with acute cholecystitis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 648-650.
[11]	Ming Jiang, Rui Luo, Chengchao Long. Diagnosis and treatment of obturator hernia: An experience of 73 cases over 10 years [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 706-710.
[12]	Yongsheng Li, Jiahe Sun, Shuwei Guo, Yikang Lu, Hongzhou Liu. Short-term postoperative complications and their influencing factors in elderly patients with colorectal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 962-967.
[13]	Jun Wang, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Libin Suo, Jun Chen, chengli Miao, Chenghua Luo. Retrospective analysis of anesthesia management of massive transfusion patients undergoing retroperitoneal tumor resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 844-849.
[14]	Libin Suo, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Jun Wang, Jun Chen, Chengli Miao, Chenghua Luo. Key points of anesthesia management and prognostic factors in patients undergoing primary retroperitoneal paraganglioma resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 771-776.
[15]	Qing Dong, Fei Ding, Hao Guo, Feng Li. Expression and clinical significance of expression of Nesfatin-1/NUCB2 in early gastric cancer associated with Helicobacter pylori infection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 783-789.

Please choose a citation manager

Content to export